Kane Launches New Corporate Brand and Redesigned Website
Refreshed identity reflects Kane’s focus on clinical biofilm science, advanced wound care and commercialization WINNIPEG, Manitoba, Oct.
19, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V: KNE) (the “Company,” “Kane” o
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.